FDA Confirms Johnson & Johnson Single-Dose Vaccine Is 66% Effective And Safe

Pharmaceutical company Johnson & Johnson’s single-dose COVID-19 vaccine has proven to be safe and considerably effective in preventing severe symptoms of the virus. The Food and Drug Administration (FDA) released a briefing analyzing results from a Johnson & Johnson clinical trial in preparation for an independent advisory panel scheduled for Thursday. The panel will discuss if Johnson & Johnson’s vaccine should be authorized for children under 18 years old. The FDA’s findings confirmed that the Johnson & Johnson vaccine was 66% effective in all trials against COVID-19. During the 28-day clini…

Read More

HEDGE accordingly